SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,020,915 | -8.3% | 8,422 | -13.4% | 0.00% | 0.0% |
| Q2 2023 | $1,113,249 | +2.3% | 9,721 | +23.2% | 0.00% | 0.0% |
| Q1 2023 | $1,087,754 | +197.0% | 7,892 | +179.3% | 0.00% | +100.0% |
| Q4 2022 | $366,193 | +21.3% | 2,826 | +3.5% | 0.00% | 0.0% |
| Q3 2022 | $302,000 | -63.3% | 2,731 | -43.5% | 0.00% | 0.0% |
| Q4 2020 | $824,000 | +17.0% | 4,834 | -3.6% | 0.00% | 0.0% |
| Q3 2020 | $704,000 | +136.2% | 5,014 | +170.2% | 0.00% | – |
| Q2 2020 | $298,000 | -35.1% | 1,856 | -60.4% | 0.00% | -100.0% |
| Q1 2020 | $459,000 | -39.5% | 4,692 | -20.2% | 0.00% | 0.0% |
| Q4 2019 | $759,000 | +32.0% | 5,882 | -23.0% | 0.00% | 0.0% |
| Q3 2019 | $575,000 | -77.0% | 7,636 | -53.5% | 0.00% | -66.7% |
| Q2 2019 | $2,495,000 | -2.1% | 16,420 | -23.2% | 0.00% | 0.0% |
| Q1 2019 | $2,548,000 | +15.7% | 21,377 | +5.9% | 0.00% | 0.0% |
| Q4 2018 | $2,202,000 | -46.8% | 20,181 | -21.2% | 0.00% | -25.0% |
| Q3 2018 | $4,138,000 | -55.8% | 25,618 | -63.8% | 0.00% | -55.6% |
| Q2 2018 | $9,365,000 | +43.2% | 70,849 | -19.7% | 0.01% | +28.6% |
| Q1 2018 | $6,540,000 | +63.0% | 88,276 | +22.4% | 0.01% | +75.0% |
| Q4 2017 | $4,012,000 | +8.6% | 72,100 | -11.5% | 0.00% | 0.0% |
| Q3 2017 | $3,695,000 | +107.4% | 81,468 | +54.1% | 0.00% | +100.0% |
| Q2 2017 | $1,782,000 | +15.0% | 52,868 | +1.0% | 0.00% | 0.0% |
| Q1 2017 | $1,550,000 | +35.5% | 52,367 | +25.5% | 0.00% | 0.0% |
| Q4 2016 | $1,144,000 | +273.9% | 41,719 | +737.6% | 0.00% | – |
| Q3 2016 | $306,000 | -32.6% | 4,981 | -78.6% | 0.00% | -100.0% |
| Q1 2016 | $454,000 | -63.4% | 23,268 | -27.7% | 0.00% | -50.0% |
| Q4 2015 | $1,242,000 | +126.6% | 32,200 | +88.6% | 0.00% | +100.0% |
| Q3 2015 | $548,000 | -16.0% | 17,075 | -46.6% | 0.00% | -50.0% |
| Q4 2013 | $652,000 | -70.3% | 32,000 | -31.2% | 0.00% | -75.0% |
| Q3 2013 | $2,196,000 | +90.0% | 46,488 | +53.1% | 0.01% | +100.0% |
| Q2 2013 | $1,156,000 | +29.3% | 30,373 | -12.3% | 0.00% | 0.0% |
| Q4 2012 | $894,000 | – | 34,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |